<DOC>
	<DOCNO>NCT01181609</DOCNO>
	<brief_summary>This study ass efficacy safety intravenous Avastin combination chemotherapy regimens second-line treatment metastatic cancer colon rectum . The anticipated time study treatment disease progression .</brief_summary>
	<brief_title>A Study Avastin ( Bevacizumab ) Combined With Chemotherapy Patients With Metastatic Cancer Colon Rectum</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Patients metastatic colon rectal cancer , progress relapse firstline treatment ; Women childbearing potential must use adequate contraception least 6 month last dose bevacizumab . Patients metastatic colon rectal cancer schedule firstline systemic treatment ; Untreated brain metastasis , spinal cord compression primary brain tumour ; Pregnant lactate woman ; Major surgical procedure , open biopsy , significant traumatic injury within 28 day prior study start ; Treatment investigational drug , participation another investigational study , within 30 day prior enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>